Opportunity Information: Apply for CDC RFA GH17 1721
Apply for CDC RFA GH17 1721
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Aug 05, 2016.
- Applicants must submit their applications by Oct 04, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $465,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under PEPFAR" is a U.S. government-funded cooperative agreement designed to strengthen HIV service delivery in Guyana by working through local indigenous organizations and faith-based affiliated service sites. The central aim is to expand access to high-quality antiretroviral therapy (ART) clinical services and to improve how quickly and consistently people living with HIV are connected to care, started on treatment, and supported to remain on treatment over time. While the award supports clinical service improvements, it is also built around technical assistance, meaning the recipient is expected to help sites and local partners build durable systems and skills rather than relying on short-term fixes.
The program is explicitly focused on improving outcomes for key populations and others who face barriers to HIV services. In practice, this means tailoring prevention, care, and treatment approaches to fit the realities of the communities being served, including addressing stigma, confidentiality concerns, and practical access issues that can interrupt care. A major priority is strengthening linkage to care (moving people smoothly from testing or diagnosis into ongoing clinical treatment) and retention on ART (supporting people to stay engaged in care and adhere to treatment). The opportunity emphasizes sustainability within faith-based affiliated sites, signaling an intent to build long-lasting capacity and service models that can continue functioning effectively beyond the period of intensive external support.
Several core strategies are highlighted in the description. One is increased engagement and coordination between clinical teams and community-based care and support organizations. This reflects an understanding that clinical care alone is often not enough to keep people in treatment; patients may need community follow-up, support navigating the health system, counseling, and help overcoming social or logistical barriers. Another strategy is continuous quality improvement (CQI) for clinical management, which typically involves routinely reviewing performance data, identifying gaps in service delivery (such as delays in ART initiation, missed appointments, or poor viral load monitoring), testing changes, and standardizing practices that improve patient outcomes. The FOA also calls for a cyclical approach to collecting key population risk factor information and other sensitive data, indicating that data collection is expected to be ongoing, structured, and used for program refinement, while recognizing that the information involved can be sensitive and must be handled carefully.
A key implementation focus is piloting strategies and service delivery models that can raise ART coverage and make treatment delivery more efficient at these faith-based sites. The FOA specifically mentions earlier ART initiation through "test and start," which refers to starting treatment as soon as possible after diagnosis rather than waiting for additional eligibility thresholds. It also mentions patient classification approaches to reduce how often stable patients need to visit clinics or pharmacies, which can lower the burden on both patients and facilities. By spacing visits for stable patients, sites can free up clinical capacity to serve more people, while also making it easier for patients to remain in care by reducing travel time, costs, and time away from work or family obligations.
Administratively, this opportunity was issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), under PEPFAR, with the funding opportunity number CDC RFA GH17-1721. It is a discretionary health funding opportunity using a cooperative agreement mechanism, which generally implies substantial involvement by the CDC in collaboration, guidance, and oversight during the project period. The CFDA number listed is 93.067. Eligibility is described as unrestricted, meaning a wide range of entity types could apply as long as they meet any additional criteria stated in the full notice. The opportunity anticipated a single award, with an award ceiling of $465,000. The FOA was created on August 5, 2016, and had an original closing date of October 4, 2016, with electronic submissions due by 11:59 p.m. Eastern Time on the deadline.
Overall, the grant is structured around a practical combination of service strengthening, site-level quality improvement, community-clinic coordination, and targeted pilots meant to increase ART uptake and long-term retention. The emphasis on local indigenous partners and faith-based affiliated settings reflects a deliberate strategy to work through trusted local structures to reach people who might otherwise be missed, while building systems that can sustain high-quality HIV treatment and support over time.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under PEPFAR."
Which U.S. government agency issued this funding opportunity?
The funding opportunity was issued by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), under PEPFAR.
What is the funding opportunity number (FOA number)?
The funding opportunity number is CDC RFA GH17-1721.
What is the CFDA number listed for this program?
The CFDA number listed is 93.067.
What type of award mechanism is being used?
This is a cooperative agreement, which generally means CDC has substantial involvement through collaboration, guidance, and oversight during the project period.
Is this a discretionary health funding opportunity?
Yes. It is described as a discretionary health funding opportunity.
Where is the program focused geographically?
The program is focused on the Republic of Guyana.
What is the central aim of this cooperative agreement?
The central aim is to strengthen HIV service delivery in Guyana by working through local indigenous organizations and faith-based affiliated service sites to expand access to high-quality antiretroviral therapy (ART) clinical services and improve linkage to care and retention on treatment.
What does the opportunity mean by improving "linkage to care"?
It refers to moving people smoothly from HIV testing or diagnosis into ongoing clinical treatment, including timely connection to services and initiation of ART.
What does the opportunity mean by improving "retention on ART"?
It refers to supporting people living with HIV to stay engaged in care over time and continue adhering to antiretroviral therapy so treatment is sustained.
Does the award focus only on clinical services, or also on technical assistance?
It includes clinical service improvements and is built around technical assistance. The recipient is expected to help sites and local partners build durable systems and skills rather than relying on short-term fixes.
Who are the primary partners or service settings emphasized in this opportunity?
The opportunity emphasizes working through local indigenous organizations and faith-based affiliated service sites to strengthen HIV prevention, care, and treatment service delivery.
Is the program designed to improve outcomes for particular groups?
Yes. It is explicitly focused on improving outcomes for key populations and others who face barriers to HIV services.
What kinds of barriers to HIV services are highlighted?
The description notes barriers such as stigma, confidentiality concerns, and practical access issues that can interrupt care.
How does the opportunity address sustainability?
A major emphasis is sustainability within faith-based affiliated sites, with the intent to build long-lasting capacity and service models that can continue functioning effectively beyond periods of intensive external support.
What core strategies are highlighted to strengthen HIV service delivery?
Highlighted strategies include stronger coordination between clinical teams and community-based care and support organizations, continuous quality improvement (CQI) for clinical management, ongoing (cyclical) collection of key population risk factor information and other sensitive data, and piloting service delivery strategies to increase ART coverage and efficiency.
Why is coordination between clinics and community-based organizations emphasized?
The opportunity reflects the idea that clinical care alone may not be enough to keep people in treatment, and that patients may need community follow-up, counseling, support navigating the health system, and help addressing social or logistical barriers.
What is continuous quality improvement (CQI) in the context of this FOA?
CQI is described as routinely reviewing performance data, identifying gaps in service delivery (such as delays in ART initiation, missed appointments, or poor viral load monitoring), testing changes, and standardizing practices that improve patient outcomes.
What does the FOA say about collecting sensitive information?
It calls for a cyclical approach to collecting key population risk factor information and other sensitive data, indicating collection is expected to be ongoing, structured, and used for program refinement, with recognition that the information is sensitive and must be handled carefully.
What kinds of service delivery models or pilots are encouraged?
The FOA encourages piloting strategies and service delivery models that raise ART coverage and make treatment delivery more efficient at faith-based sites.
What is meant by "test and start" in this opportunity?
"Test and start" refers to starting ART as soon as possible after HIV diagnosis rather than waiting for additional eligibility thresholds.
How does the opportunity propose reducing the burden of frequent clinic or pharmacy visits?
It mentions patient classification approaches that reduce how often stable patients need to visit clinics or pharmacies, which can lower burdens for patients and facilities and free clinical capacity for more people.
What is the expected impact of spacing visits for stable patients?
Spacing visits can reduce travel time, costs, and time away from work or family for patients, while allowing facilities to serve more people by focusing clinical capacity where it is most needed.
How many awards were anticipated?
The opportunity anticipated a single award.
What is the award ceiling?
The award ceiling listed is $465,000.
Who is eligible to apply?
Eligibility is described as unrestricted, meaning a wide range of entity types could apply as long as they meet any additional criteria stated in the full notice.
When was the FOA created?
The FOA was created on August 5, 2016.
What was the original application closing date?
The original closing date was October 4, 2016.
What time were electronic submissions due on the deadline?
Electronic submissions were due by 11:59 p.m. Eastern Time on the deadline date.
What is the overall structure or approach of the grant?
The grant is structured around strengthening clinical services, implementing site-level quality improvement, improving coordination between community and clinical partners, and testing targeted pilots meant to increase ART uptake and long-term retention, with an emphasis on durable capacity in local indigenous and faith-based affiliated settings.
Browse more opportunities from the same category: Health
Next opportunity: Developing a Standard of Care for Cruise Tourism in the United States Arctic Waterways
Previous opportunity: Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH17 1721
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH17 1721) also looked into and applied for these:
| Funding Opportunity |
|---|
| Support for Quality Facility and Community-based Antiretroviral Therapy (ART) for Adults and Children in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1718 Funding Number: CDC RFA GH17 1718 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR Apply for CDC RFA GH17 1755 Funding Number: CDC RFA GH17 1755 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $18,000,000 |
| Projecto de Saúde Para Todos (Health for All, or HFA) Apply for NFO RFA 654 16 000004 Funding Number: NFO RFA 654 16 000004 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $63,000,000 |
| Program Expansion Supplement: Scaling up Voluntary Medical Male Circumcision through improvement in HIV prevention under PEPFAR Apply for CDC RFA GH13 13280401SUPP16 Funding Number: CDC RFA GH13 13280401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Human Heredity and Health in Africa (H3Africa): Coordinating Center (U24) Apply for RFA RM 16 017 Funding Number: RFA RM 16 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| Human Heredity and Health in Africa (H3Africa): Informatics Network (U24) Apply for RFA RM 16 011 Funding Number: RFA RM 16 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Vector Control Strategies- Enhancing Capacity for Vector Surveillance and Control to Prevent Zika, Dengue and Chikungunya Infection in Puerto Rico - Financed in part by Prevention and Public Health Funds Apply for CDC RFA CK16 1608PPHF2016 Funding Number: CDC RFA CK16 1608PPHF2016 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 15050104SUPP16 Funding Number: CDC RFA CK15 15050104SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Assist the Ministry of Health to Provide Critical Human Resources for Health to Achieve HIV Epidemic Control in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1715 Funding Number: CDC RFA GH17 1715 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| Support for the National Blood Bank Services in the Implementation and Expansion of Blood Safety Activities in Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1746 Funding Number: CDC RFA GH17 1746 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,650,000 |
| Strengthening Capacity of HIV/AIDS Treatment in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1761 Funding Number: CDC RFA GH17 1761 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,600,000 |
| Enhancing Sustainable and Integrated Health, Strategic Information and Laboratory Systems for Quality Comprehensive HIV Services through Technical Assistance to the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1750 Funding Number: CDC RFA GH17 1750 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $720,000 |
| Strengthening Local Ownership and Sustainable Provision of Quality Comprehensive HIV/AIDS Services for Inmates in the Federal Prison Administration (FPA) and Regional Prisons of Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1777 Funding Number: CDC RFA GH17 1777 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01) Apply for RFA HL 17 014 Funding Number: RFA HL 17 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $268,500 |
| USAID’s Improving Nutrition through Community-based Approaches (INCA) Activity Apply for RFA 388 16 000010 Funding Number: RFA 388 16 000010 Agency: Agency for International Development, Bangladesh USAID-Dhaka Category: Health Funding Amount: $4,500,000 |
| Strengthening of Ghana National Health Management Systems in the Areas of Strategic Information Systems and Laboratory Capacity Building under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1732 Funding Number: CDC RFA GH17 1732 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program Apply for HRSA 17 030 Funding Number: HRSA 17 030 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Family Leadership in Language and Learning (FL3) Apply for HRSA 17 061 Funding Number: HRSA 17 061 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Universal Newborn Hearing Screening and Intervention Program Apply for HRSA 17 059 Funding Number: HRSA 17 059 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 17 053 Funding Number: HRSA 17 053 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH17 1721", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.